CLL cells showed a trend for inhibition of CXCL12-directed migration by 5 μM PGE2 when compared to cells treated only with CXCL12 (Figure 3B; P = 0.102). This evidence concerns the gene CXCL12 and B-cell chronic lymphocytic leukemia.